Novartis’ T-cell therapy for blood cancer, developed with Penn, wins European approval

The European Commission has followed the U.S. Food and Drug Administration in approving a genetically engineered T-cell therapy for certain blood cancers. The European price tag remains to be seen. AdChoices 1 2 3 YOU MAY LIKE Sponsored Links by Microsoft … (본문 전체 8/28/2018 8:23 AM)

1 thought on “Novartis’ T-cell therapy for blood cancer, developed with Penn, wins European approval”

Leave a Comment